在1000万中国新生儿中查原发性肉素缺乏症:系统性审查和元分析
Jinfu Zhou1, Guilin Li2, Yinglin Zeng1
1Medical Genetic Diagnosis and Therapy Center, Fujian Key Laboratory for Prenatal Diagnosis and Birth Defect, Fujian Maternity and Child Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350001, Fujian Province, China.
Orphanet journal of rare diseases
|July 3, 2024
概括
原发性肉氨酸缺乏症 (PCD) 影响中国每20,000名新生儿中就有1名,南部的发病率更高. 这项研究详细介绍了常见的SLC22A5基因变异,有助于未来的新生儿查工作.
科学领域:
- 遗传学 是一个遗传学.
- 代谢障碍 代谢障碍 代谢障碍
- 流行病学 流行病学
背景情况:
- 原发性肉氨酸缺乏症 (PCD) 是脂肪酸氧化的一种自身遗传性衰退性疾病.
- 它是由SLC22A5基因的变异引起的,其流行率和突变谱在全球范围内有所不同.
- 这项研究系统地分析了中国的PCD发病率和SLC22A5变体.
结论:
- 这一元分析提供了PCD流行率和中国常见的SLC22A5变体的全面概述.
- 观察到PCD发病率和变异频率的区域差异.
- 这些发现提供了关键的流行病学数据,以指导和改进新生儿PCD查计划.
相关概念视频
Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...


